Viewing Study NCT07155850

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:51 PM
Ignite Modification Date: 2026-01-30 @ 11:49 PM
Study NCT ID: NCT07155850
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-04
First Post: 2025-08-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC
Sponsor: BetaGlue Therapeutics SpA
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Ductal Adenocarcinoma (PDAC) View
None Locally Advanced View
None Unresectable View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LA-PDAC View
None Yttrium-90 View
None YntraDose™ View